Cargando…

Reclaiming the systems approach to paediatric safety

Detalles Bibliográficos
Autores principales:	Cheung, Ronny, Roland, Damian, Lachman, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Leading Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900242/ https://www.ncbi.nlm.nih.gov/pubmed/30798257 http://dx.doi.org/10.1136/archdischild-2018-316401

Ejemplares similares

Using reporting guidelines to publish paediatric research
por: Harron, Katie
Publicado: (2017)

COVID-19 and the paediatric acute abdomen—the emerging dilemma of PIMS-TS
por: Walker, Eleanor T., et al.
Publicado: (2022)

Achieving consensus advice for paediatricians and other health professionals: on prevention, recognition and management of conflict in paediatric practice
por: Linney, Mike, et al.
Publicado: (2019)

WHO Strategy for Collecting Safety Data in Public Health Programmes: Complementing Spontaneous Reporting Systems
por: Pal, Shanthi N., et al.
Publicado: (2013)

Developing Strategic Recommendations for Implementing Smart Pumps in Advanced Healthcare Systems to Improve Intravenous Medication Safety
por: Sutherland, Adam, et al.
Publicado: (2022)

Safety and efficacy of supplements in pregnancy
por: Brown, Benjamin, et al.
Publicado: (2020)

Anti-Tumour Necrosis Factor Therapy for Paediatric Crohn’s Disease: Improved Benefits Through Treatment Optimisation, Deeper Understanding of Its Risks, and Reduced Costs due to Biosimilar Availability
por: Cozijnsen, M. A., et al.
Publicado: (2017)

Measuring and improving the quality of NHS care for children and young people
por: Hargreaves, Dougal S, et al.
Publicado: (2019)

Ten years of the Surgical Safety Checklist
por: Weiser, T. G., et al.
Publicado: (2018)

Impact on Drug Safety of Variation in Adherence: The Need for Routinely Reporting Measures of Dose Intensity in Medication Safety Studies Using Electronic Health Data
por: Roughead, Elizabeth E., et al.
Publicado: (2015)

Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia
por: Meyer, Jonathan M., et al.
Publicado: (2023)

Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology
por: Tavares-Da-Silva, Fernanda, et al.
Publicado: (2020)

Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium Guidance
por: Banerjee, Anjan K., et al.
Publicado: (2013)

Promoting and Protecting Public Health: How the European Union Pharmacovigilance System Works
por: Santoro, Aniello, et al.
Publicado: (2017)

New Pharmacological Approaches to the Management of Premenstrual Dysphoric Disorder
por: Sundström-Poromaa, Inger, et al.
Publicado: (2023)

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
por: Bakota, Lidia, et al.
Publicado: (2016)

Pharmacological Approaches to Delaying Disability Progression in Patients with Multiple Sclerosis
por: Wiendl, Heinz, et al.
Publicado: (2015)

A Social Identity Approach to Understanding and Promoting Physical Activity
por: Stevens, Mark, et al.
Publicado: (2017)

Efficacy and safety of mycophenolate mofetil in treating immune‐related hepatitis induced by immune checkpoint inhibitor use: A retrospective study
por: Kadokawa, Yukio, et al.
Publicado: (2023)

Global Access Programs: A Collaborative Approach for Effective Implementation and Management
por: Ainge, Debra, et al.
Publicado: (2015)

Potential Safety Issues with Use of Sodium-Glucose Cotransporter 2 Inhibitors, Particularly in People with Type 2 Diabetes and Chronic Kidney Disease
por: Milder, Tamara Y., et al.
Publicado: (2020)

A Whirlwind Tour of Complex Systems
por: Putty, Madhukara S.
Publicado: (2021)

A Pragmatic Approach to Resolving Technological Unfairness: the Case of Nike’s Vaporfly and Alphafly Running Footwear
por: Dyer, Bryce
Publicado: (2020)

Theoretical and practical approaches for dietary behavior change in urban socioeconomically disadvantaged adolescents: a systematic review
por: Bel-Serrat, Silvia, et al.
Publicado: (2022)

New and Emerging Systemic Treatments for Atopic Dermatitis
por: Newsom, Megan, et al.
Publicado: (2020)

An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus
por: Trindade, Vitor Cavalcanti, et al.
Publicado: (2021)

Interrogating the Gut-Brain Axis in the Context of Inflammatory Bowel Disease: A Translational Approach
por: Collins, Stephen M
Publicado: (2020)

PARP Inhibitors in Reproductive System Cancers: Current Use and Developments
por: O’Sullivan Coyne, Geraldine, et al.
Publicado: (2017)

COVID‐19 and its effects on the digestive system and endoscopy practice
por: Aguila, Enrik John T., et al.
Publicado: (2020)

Electronic Reporting Systems in Pharmacovigilance: The Implementation of VigiFlow in Brazil
por: Vogler, Marcelo, et al.
Publicado: (2020)

The Purinergic System as a Target for the Development of Treatments for Bipolar Disorder
por: Gonçalves, Maria Carolina Bittencourt, et al.
Publicado: (2022)

Targeted Small Molecules for Systemic Lupus Erythematosus: Drugs in the Pipeline
por: Mok, Chi Chiu
Publicado: (2023)

Bruton’s Tyrosine Kinase Inhibition as an Emerging Therapy in Systemic Autoimmune Disease
por: Neys, Stefan F. H., et al.
Publicado: (2021)

Validating Intelligent Automation Systems in Pharmacovigilance: Insights from Good Manufacturing Practices
por: Huysentruyt, Kristof, et al.
Publicado: (2021)

Health Systems in High-Performance Sport: Key Functions to Protect Health and Optimize Performance in Elite Athletes
por: Drew, Michael K., et al.
Publicado: (2023)

Looking to the future: should ‘prognosis’ be heard as often as ‘diagnosis’ in medical education?
por: Croft, Peter, et al.
Publicado: (2015)

Big Data in Pharmaceutical R&D: Creating a Sustainable R&D Engine
por: Tormay, Peter
Publicado: (2015)

Plasma Pharmacokinetics of N-Acetylgalactosamine-Conjugated Small-Interfering Ribonucleic Acids (GalNAc-Conjugated siRNAs)
por: Sten, Sebastian, et al.
Publicado: (2023)

Experience and clinical efficacy of gut‐directed hypnotherapy in an Asian population with refractory irritable bowel syndrome
por: Sasegbon, Ayodele, et al.
Publicado: (2022)

Standardising the Classification of Harm Associated with Medication Errors: The Harm Associated with Medication Error Classification (HAMEC)
por: Gates, Peter J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kn1d77hdk1u78qbbtfsfi9um9u